Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Barden

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Immunology, Immunotherapy : CII|October 23, 2025
Development of antigen multimers for detection and evaluation of CAR T cellsRasmus U W Friis, Maria Ormhøj, Cecilie S Krüger-Jensen, et al.
Frontiers in Immunology|May 18, 2026
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphomaTim Schlierkamp-Voosen, Markus Barden, Helena Janning, et al.
Journal for Immunotherapy of Cancer|December 2, 2024
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell functionMarkus Barden, Patrick Ronan Elsenbroich, Vivian Haas, et al.
Frontiers in Immunology|October 10, 2024
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanomaKrasimira Aleksandrova, Jana Leise, Christoph Priesner, et al.
Nature Chemical Biology|February 19, 2026
Drug-controlled CAR T cells through the regulation of cell-cell interactionsLeo Scheller, Greta Maria Paola Giordano Attianese, Rocío Castellanos-Rueda, et al.
Cell|September 14, 2024
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacyJeremy G Baldwin, Christoph Heuser-Loy, Tanmoy Saha, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Immunology, Immunotherapy : CII|October 23, 2025
Development of antigen multimers for detection and evaluation of CAR T cellsRasmus U W Friis, Maria Ormhøj, Cecilie S Krüger-Jensen, et al.
Frontiers in Immunology|May 18, 2026
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphomaTim Schlierkamp-Voosen, Markus Barden, Helena Janning, et al.
Journal for Immunotherapy of Cancer|December 2, 2024
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell functionMarkus Barden, Patrick Ronan Elsenbroich, Vivian Haas, et al.
Frontiers in Immunology|October 10, 2024
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanomaKrasimira Aleksandrova, Jana Leise, Christoph Priesner, et al.
Nature Chemical Biology|February 19, 2026
Drug-controlled CAR T cells through the regulation of cell-cell interactionsLeo Scheller, Greta Maria Paola Giordano Attianese, Rocío Castellanos-Rueda, et al.
Cell|September 14, 2024
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacyJeremy G Baldwin, Christoph Heuser-Loy, Tanmoy Saha, et al.
Pageof 2